Home Newsfeeds Infosys Cuts Average Variable Payout To 70% For Q1 On Margin Pressure

News

Infosys Cuts Average Variable Payout To 70% For Q1 On Margin Pressure

https://www.moneycontrol.com/news/business/infosys-cuts-average-variable-payout-to-70-for-q1fy23-on-margin-pressure-9069141.html

byBenzinga Newsdesk

August 22, 2022

1 minute read

https://www.moneycontrol.com/news/business/infosys-cuts-average-variable-payout-to-70-for-q1fy23-on-margin-pressure-9069141.html

Tigress Financial Maintains Buy on Costco Wholesale, Lowers Price Target to $635

By Benzinga Newsdesk

December 21, 2:35 PM

Tigress Financial analyst Ivan Feinseth maintains Costco Wholesale (NASDAQ:COST) with a Buy and lowers the price target from $678 to $635.

COST

‘Tough Battles Ahead … For Sure:’ Musk Reacts To MegaUpload Founder Kim Dotcom’s Claims That Biden’s ‘Corruption’ Cost Tesla CEO $56B

By Anan Ashraf

February 2, 6:59 AM

Dotcom is among those who believe that Delaware judge Kathleen McCormick, responsible for revoking Musk's pay package, is working against Musk in favor of Democratic interests.

TSLA

News

Fresenius Majority-Owned Group Mabxience Has Licensing Agreement With Intas Pharmaceuticals for Autoimmune Disease Drug Etanercept

By Charles Gross

December 20, 6:02 AM

Intas Pharmaceuticals Ltd., a leading multinational pharmaceutical company, has announced today a strategic exclusive licensing agreement with mAbxience (a Fresenius Kabi majority-owned group with partial

FMS

US Stock Futures Signal Higher Start On Wall Street; Crude Oil Rises

By Lisa Levin

September 12, 5:32 AM

Pre-open movers

BYDDF

Infosys Cuts Average Variable Payout To 70% For Q1 On Margin Pressure

Related Posts

Tigress Financial Maintains Buy on Costco Wholesale, Lowers Price Target to $635

‘Tough Battles Ahead … For Sure:’ Musk Reacts To MegaUpload Founder Kim Dotcom’s Claims That Biden’s ‘Corruption’ Cost Tesla CEO $56B

Fresenius Majority-Owned Group Mabxience Has Licensing Agreement With Intas Pharmaceuticals for Autoimmune Disease Drug Etanercept

US Stock Futures Signal Higher Start On Wall Street; Crude Oil Rises